Didanosine 150 mg Chewable Tablet [Videx]
RxNorm 153834
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 153834 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: didanosine 150 mg Chewable Tablet [Videx].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
DdI 150 mg Chewable Tablet [Videx]
(Atom ID: 3855987)
SBD
Semantic Branded Drug (SBD):
Didanosine 150 mg Chewable Tablet [Videx]
(Atom ID: 12363992)
SY
Synonym (SY):
Dideoxyinosine 150 mg Chewable Tablet [Videx]
(Atom ID: 3855988)
SY